NM_000138.5:c.6658C>T

Variant summary

Our verdict is Pathogenic.
>+14 Pathogenic
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 16 classification points (ACMG Germline Pathogenicity v2019). PVS1PS2_SupportingPS4_SupportingPM2PP5_Strong

The NM_000138.5(FBN1):c.6658C>T (p.Arg2220Ter) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant is predicted to lead to nonsense-mediated mRNA decay (NMD). The variant allele was found at a cumulative frequency of 0.000000684 (AC=1) in the gnomAD database across 1,461,324 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.0000009. In-silico predictor (BayesDel (noAF)) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. The affected nucleotide is highly conserved across species (PhyloP 100-way vertebrate score: 10.00). Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0 ( 0 hom. )

Consequence

FBN1
NM_000138.5 stop_gained

Predictors

5
2
AlphaGenome AVI: 37 : Pathogenic

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:14

Conservation

PhyloP100: 10.0

Publications

2 publications found
Genes affected
FBN1 (HGNC:3603): (fibrillin 1) This gene encodes a member of the fibrillin family of proteins. The encoded preproprotein is proteolytically processed to generate two proteins including the extracellular matrix component fibrillin-1 and the protein hormone asprosin. Fibrillin-1 is an extracellular matrix glycoprotein that serves as a structural component of calcium-binding microfibrils. These microfibrils provide force-bearing structural support in elastic and nonelastic connective tissue throughout the body. Asprosin, secreted by white adipose tissue, has been shown to regulate glucose homeostasis. Mutations in this gene are associated with Marfan syndrome and the related MASS phenotype, as well as ectopia lentis syndrome, Weill-Marchesani syndrome, Shprintzen-Goldberg syndrome and neonatal progeroid syndrome. [provided by RefSeq, Apr 2016]
FBN1 Gene-Disease associations (from GenCC):
  • familial thoracic aortic aneurysm and aortic dissection
    Inheritance: AD, Unknown Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Marfan syndrome
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
  • Acromicric dysplasia
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
  • progeroid and marfanoid aspect-lipodystrophy syndrome
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
  • stiff skin syndrome
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Weill-Marchesani syndrome 2, dominant
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • geleophysic dysplasia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • isolated ectopia lentis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • neonatal Marfan syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Weill-Marchesani syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • ectopia lentis 1, isolated, autosomal dominant
    Inheritance: AD Classification: LIMITED Submitted by: G2P
  • Shprintzen-Goldberg syndrome
    Inheritance: AD, Unknown Classification: LIMITED, NO_KNOWN Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000138.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Pathogenic. The variant received 16 points.

PVS1Null variant in LOF gene
Frameshift/stop-gained, NMD predicted, LoF disease mechanism — very strong (PVS1); Stop-gained (exon 55 of 66) at amino acid 2220 of 2871, predicted to trigger nonsense-mediated mRNA decay. Loss of function is a known disease mechanism for this gene.
PS2Confirmed de novo variant
ClinVar submission reports a confirmed de novo occurrence (PS2_Supporting); SCV000829945: In at least one individual the variant was observed to be de novo.; SCV002767685: Subsequent analysis of parental samples indicated this variant to be de novo.; SCV000787253: affected individual with de novo origin (ClinVar observation); SCV004045939: affected individual with de novo origin (ClinVar observation)
PS4Prevalence increased in affected individuals
Rare variant reported in affected individuals by ≥2 independent ClinVar submitters (PS4_Supporting); 7 ClinVar submitter(s) report the variant in affected individuals; SCV000058896: The Arg2220X variant (FBN1) has been reported in two Japanese probands with clin ical features of Marfan syndrome and was absent in 100 control chromosomes from healthy Japanese individuals (Matsukawa 2001, Ogawa 2011). In addition, this var iant has been identified in 1/1090 chromosomes from a broad, though clinically a nd racially unspecified population (dbSNP rs113001196).; SCV000233877: Identified in a patient with isolated TAAD (iTAAD) in published literature (PMID: 33824467); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 39843441, 34916231, 36517271, 25525159, 21907952, 17657824, 12938084, 23684891, 22772377, 27112580, 29357934, 26787436, 35058154, 33824467, 11139245); SCV000741017: This alteration has been reported in cohorts of subjects with FBN1-related disease (Matsukawa R et al. Hum Mutat, 2001;17:71-2; Comeglio P et al. Hum Mutat, 2007 Sep;28:928; Somers AE et al. Am J Med Genet A, 2016 Jul;170:1786-90; Becerra-Muñoz VM et al. Orphanet J Rare Dis, 2018 Jan;13:16; Meester JAN et al. Genet Med, 2022 May;24:1045-1053).; SCV000829945: This premature translational stop signal has been observed in individual(s) with Marfan syndrome (PMID: 11139245, 17657824, 22772377, 23684891, 27112580, 29357934).; SCV000885419: The FBN1 c.6658C>T; p.Arg2220Ter variant (rs113001196) has been described in several individuals affected with Marfan syndrome (Attanasio 2013, Collod-Beroud 2003, Comeglio 2007, Matsukawa 2001, Ogawa 2011, Wang 2013).; (+2 more)
PM2Absent/extremely low in population databases
Very rare in gnomAD for AD/XL gene (popmax AF < threshold/10) — PM2; GnomAD popmax AF = 0.0000009 — very rare for AD+AR gene (threshold 0.0001) — PM2 moderate
PP5Reputable source reports pathogenic
ClinVar 2-star pathogenic — strong (PP5); ClinVar submissions overwhelmingly pathogenic (≥10 total, ≥80% P/LP, <10% B/LB) — strong (PP5, count-based); ClinVar germline classification: Pathogenic/Likely Pathogenic, 2 star(s). ClinVar submissions strongly and reliably favor pathogenicity (14/14 total P/LP)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_000138.5. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

FBN1 NM_000138.5
MANE Select
HGVSc / HGVSpc.6658C>Tp.Arg2220Ter
Exon rankExon 55 of 66
stop_gained
Prot: NP_000129.3
FBN1 NM_001406716.1
HGVSc / HGVSpc.6658C>Tp.Arg2220Ter
Exon rankExon 54 of 65
stop_gained
Prot: NP_001393645.1

Ensembl Transcripts

FBN1 ENST00000316623.10
MANE Select
HGVSc / HGVSpc.6658C>Tp.Arg2220Ter
Exon rankExon 55 of 66
stop_gained
Prot: ENSP00000325527
FBN1 ENST00001134742.1
HGVSc / HGVSpc.6658C>Tp.Arg2220Ter
Exon rankExon 55 of 66
stop_gained
Prot: ENSP00000806984
FBN1 ENST00000559133.6
HGVSc / HGVSpc.6658C>Tp.Arg2220Ter
Exon rankExon 55 of 67
stop_gainedNMD_transcript
Prot: ENSP00000453958

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 4 sources
GnomAD3 genomes
Cov:32
GnomAD4 exome
AF: 6.84e-7
AC:1
Hom:0
AN:1461324
Cov:32
GnomAD4 genome
Cov:32
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.00
AC:0
Hom:0
AN:187138
Showing 4 sources

ClinVar

ClinVar submissions
Significance:Pathogenic/Likely pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
6
-
-
Marfan syndrome (6)
1
-
-
Familial thoracic aortic aneurysm and aortic dissection (1)
1
-
-
FBN1-related disorder (1)
1
-
-
Isolated thoracic aortic aneurysm (1)
1
-
-
Marfan syndrome;C4707243:Familial thoracic aortic aneurysm and aortic dissection (1)
1
-
-
Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections (1)
1
-
-
not provided (1)
1
-
-
not specified (1)
1
-
-
Thoracic aortic aneurysm or dissection (1)

Computational Scores

AlphaGenome AVI
Pathogenic37
BayesDel_addAF
Pathogenic0.63D
BayesDel_noAF
Pathogenic0.58
CADD
Pathogenic46
DANN
Uncertain1.0
Eigen
Pathogenic0.96
Eigen_PC
Pathogenic0.85
FATHMM_MKL
Uncertain0.93D
GPN-Star LLR
N/A-11
GPN-Star score
N/A11
Mutation Taster
N/A1/199disease causing (ClinVar)
PhyloP100
Pathogenic10
Showing 12 of 12 scores

Splicing Scores

Pangolin (max)
Benign0.090
SpliceAI score (max)
Benign0.020
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.